PHI with Cerebral ischemia
How does this condition affect your private health insurance?
Zerebraler Durchblutungsmangel, also known as cerebral hypoperfusion or ischemia, describes a condition where the brain receives insufficient blood flow. This critical reduction in oxygen and nutrient supply can lead to various neurological impairments, ranging from temporary symptoms to permanent brain damage. Causes often include atherosclerosis, blood clots, severe hypotension, cardiac arrest, or conditions narrowing blood vessels. Symptoms may involve dizziness, confusion, vision problems, speech difficulties, weakness, or numbness. If prolonged or severe, it can result in a stroke. Chronic forms can contribute to vascular dementia, impacting cognitive functions over time. Early diagnosis and treatment are crucial to minimize damage and improve outcomes.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Acute events can last minutes (e.g., TIA) to hours/days (onset of stroke), with symptoms persisting and requiring immediate medical attention.
Duration of Illness (Lifetime)
Can be a one-time event (e.g., TIA with full recovery) or a chronic condition leading to progressive neurological decline (e.g., vascular dementia) or recurrent ischemic events requiring ongoing management.
Cost of Treatment (Initial)
High. Includes emergency care, hospitalization, diagnostic imaging (CT/MRI), acute interventions (e.g., thrombolysis, thrombectomy), and initial rehabilitation. Can range from several thousands to tens of thousands of Euros depending on severity and required procedures.
Cost of Treatment (Lifetime)
Very high. Includes long-term medication (e.g., antiplatelets, anticoagulants), ongoing rehabilitation (e.g., physiotherapy, speech, occupational therapy), potential home care, and management of recurrent events or chronic cognitive decline. Can easily exceed hundreds of thousands over a lifetime for severe cases.
Mortality Rate
Varies significantly. For severe acute ischemic events (e.g., large stroke), 30-day mortality rates can be 10-30%. Chronic, mild hypoperfusion has a lower direct mortality but contributes to overall health decline and increased risk of future events.
Risk of Secondary Damages
High. Common secondary damages include neurological deficits (e.g., motor weakness, sensory loss, aphasia, visual field defects), cognitive impairment (e.g., memory, executive function), depression, anxiety, and impaired quality of life.
Probability of Full Recovery
Varies widely. For transient ischemic attacks (TIAs), complete recovery is common (approximately 70-80%). For ischemic strokes, only about 10-20% achieve complete recovery without significant residual deficits, while many experience moderate to severe disability.
Underlying Disease Risk
High (over 70-80%). Often associated with atherosclerosis, hypertension, diabetes mellitus, hyperlipidemia, atrial fibrillation, other heart diseases, and smoking.